Loading stock data…
HUM
$233.63-2.81 (-1.19%)
Market ClosedLast close May 1
Humana Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Humana Inc. in the Healthcare sector is trading at $233.63. The stock is currently 26% below its 52-week high of $315.35, remaining 2.1% below its 200-day moving average. Technical signals show overbought RSI of 78 and bullish MACD crossover, explaining why HUM maintains its current current market pressure. The Whystock Score of 0/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 78) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$233.63
Potential Downside
9.4%
Whystock Fair Value$211.60
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus24 analysts
Hold
Mean target$240.50+2.9%
Range$146.00 – $333.00
Fundamentals
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, inclu...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$25.81B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
21.84
Beta
Defensive asset. Lower volatility than the S&P 500.
0.45
Div Yield
Strong income play. Yield provides a meaningful total return floor.
165.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
8.93%
Volume
Today's trading volume
1.30M
Recent News
UnitedHealth or Humana: Which Managed Care Stock Had the Healthiest Returns in April?
The April scoreboard is in for managed care. UnitedHealth Group (NYSE:UNH) stock and Humana (NYSE:HUM) stock both staged impressive rallies, yet UnitedHealth won by just a few basis points (bps). UNH stock climbed 37% in April, finishing at $370.48 on April 30. HUM stock rose 36%, closing at $236.44. It’s a photo finish, but UnitedHealth ... UnitedHealth or Humana: Which Managed Care Stock Had the Healthiest Returns in April?
Cigna Q1 Earnings Beat Estimates on Strong Evernorth Unit
CI beats Q1 EPS estimates as Evernorth revenues jump 9% despite rising pharmacy costs; 2026 EPS outlook lifted to at least $30.35.
Humana Q1 Earnings Call Highlights
Humana (NYSE:HUM) executives said the company’s first-quarter performance tracked as expected and reiterated its longer-term plan to rebuild Medicare Advantage profitability, while also outlining ongoing operational changes, balance-sheet actions, and growth initiatives at CenterWell. Management sa
Humana Inc (HUM) Q1 2026 Earnings Call Highlights: Strategic Growth and Financial Prudence ...
Humana Inc (HUM) reports robust Medicaid membership growth and strategic financial maneuvers while navigating cost trends and industry uncertainties.
Earnings live updates: Oil majors report impact from Iran war, Reddit stock surges to end busy earnings week
Earnings season is in full swing, with five of the "Magnificent Seven" reporting first quarter results this week